Nagpur, Maharashtra
GST No. 27AMPPS8870F1Z9
Call 08048989600
Send Enquiry
| Brand | Budecort |
| Manufacturer | Cipla Ltd |
| Prescription/Non prescription | Prescription |
| Packaging Type | Box |
| Country of Origin | Made in India |
BUDESONIDE is a nasal spray containing budesonide, a corticosteroid. It prevents the release of substances in the body that cause inflammation. Budesonide is used to treat nasal symptoms such as congestion, sneezing, and runny nose caused by seasonal or year-round allergies. Budesonide is also used to keep nasal polyps from coming back after surgery to remove them. Budesonide may also be used for purposes other than those listed in this medication guide.
What should I tell my health care provider before I take this medicine?You should not use this Budesonide if you are allergic to budesonide.
Before using Budesonide, tell your doctor if you have been sick or had an infection of any kind. You may not be able to use Budesonide until you are well.
Also tell your doctor if you are allergic to any drugs, or if you have:
FDA pregnancy category B. Budesonide is not expected to be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. It is not known whether budesonide passes into breast milk or if it could harm a nursing baby. Do not use Budesonide without telling your doctor if you are breast-feeding a baby.
View Complete details
Brand Name: | Ipravent Inhaler |
Generic Name: | Ipratropium bromide 20 MCG |
Company: | CIPLA |
Strength: | 20 MCG |
packing: | 200 MD Inhaler |
Type: | Inhaler |
Uses: | ASTHAMA |
View Complete details
Brand Name: | Budecort Inhaler |
Generic Name: | Budesonide |
Company: | Cipla |
Strength: | 100mcg |
Packing: | 100md |
Type: | Inhaler |
Use: | Asthama |
Budecort Inhaler contains Budesonide which is a glucocorticoid steroid for the treatment of asthma, non-infectious rhinitis (including hay fever and other allergies), and for treatment and prevention of nasal polyposis. Additionally, it is used for Crohn''s disease (inflammatory bowel disease).
It is marketed by AstraZeneca as a nasal inhalant under the brand name Rhinocort (in Denmark, as Rhinosol), as an oral inhalant under the brand name Pulmicort, and as either an enema or a modified release oral capsule under the brand name Entocort. It is also sold in combination with (Oxis) in a single inhaler, under the brand name Symbicort. In Brazil it''s marketed by Eurofarma under the brand name Noex.
View Complete details